The Chinese University of Hong Kong

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1963-01-01

Employees: -

Market Cap: -

Website: http://www.cuhk.edu.hk

Clinical Trials

BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study)

Phase 4

Completed

Conditions: Hypertension

Interventions: Drug: Bisoprolol 2.5 mg
Drug: Placebo

First Posted Date: 2015-03-26

Last Posted Date: 2021-01-06

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 100

Registration Number: NCT02398929

Locations: 🇭🇰
Brian Tomlinson, Hong Kong, Hong Kong

Problem-solving-based Bibliotherapy Program for Family Caregivers

Not Applicable

Completed

Conditions: Psychotic Disorders
Schizophrenia

Interventions: Behavioral: Self-learning program
Behavioral: Psycho-education program (in Phase 2)

First Posted Date: 2015-03-18

Last Posted Date: 2020-09-14

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 422

Registration Number: NCT02391649

Locations: 🇭🇰
Li Ka Shing Specialty OPD, Sha Tin, NT, Hong Kong
🇭🇰
TM Psy Centre, Tuen Mun, NT, Hong Kong

Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule

Phase 2

Completed

Conditions: Intermittent Claudication
Peripheral Arterial Disease

Interventions: Drug: Danshen Gegen Capsule
Drug: Placebo

First Posted Date: 2015-03-05

Last Posted Date: 2019-07-29

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 107

Registration Number: NCT02380794

Locations: 🇭🇰
Prince of Wales Hospital, Shatin, New Territories, Hong Kong

Intervention Assessing the Role of Exercise Program and Nutrition Supplement for Sarcopenia

Not Applicable

Completed

Conditions: Sarcopenia

Interventions: Other: Waitlist control group
Behavioral: Exercise program alone
Dietary Supplement: Combined exercise program and nutrition supplement

First Posted Date: 2015-02-27

Last Posted Date: 2018-01-12

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 113

Registration Number: NCT02374268

Locations: 🇨🇳
Chinese University of Hong Kong, Hong Kong, China

Lifestyle Intervention and Prevention of Gestational Diabetes Mellitus

Not Applicable

Completed

Conditions: Gestational Diabetes Mellitus

Interventions: Behavioral: Lifestyle modification program

First Posted Date: 2015-02-23

Last Posted Date: 2017-02-06

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 220

Registration Number: NCT02368600

Locations: 🇨🇳
Chinese University of Hong Kong, Hong Kong, China

Early Risk Stratification in ED Chest Pain Patients

Completed

Conditions: Acute Coronary Syndrome

Interventions: Other: Thrombolysis in myocardial infarction score
Biological: routine blood test for hs-cTnT
Other: HEART score

First Posted Date: 2015-02-18

Last Posted Date: 2021-04-15

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 602

Registration Number: NCT02364271

Locations: 🇨🇳
Prince of Wales Hospital, Hong Kong, China

Genetic Testing and Counseling to Reduce Diabetic Complications

Not Applicable

Completed

Conditions: Diabetic Complication

Interventions: Other: Normal usual care
Behavioral: Personalized Risk Counselling

First Posted Date: 2015-02-18

Last Posted Date: 2022-03-21

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 435

Registration Number: NCT02364323

Locations: 🇭🇰
Prince of Wales Hospital, Shatin, Hong Kong

BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycaemia in Subjects With Pre-Diabetes

Phase 2

Completed

Conditions: Pre-Diabetes

Interventions: Drug: BTI320
Drug: BTI320 matching placebo

First Posted Date: 2015-02-09

Last Posted Date: 2017-04-25

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 60

Registration Number: NCT02358668

Locations: 🇭🇰
The Chinese University of Hong Kong, Shatin, Hong Kong

Drug to Prevent Pneumonia in the Tube Fed

Phase 4

Terminated

Conditions: Pneumonia
Neurological Dysphagia

Interventions: Drug: Angiotensin converting enzyme inhibitor (Lisinopril)
Drug: Placebo

First Posted Date: 2015-02-09

Last Posted Date: 2015-02-09

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 93

Registration Number: NCT02358642

Locations: 🇭🇰
Prince of Wales Hospital, Hong Kong, Hong Kong

EUS-guided CGN for Inoperable Cancer

Phase 2

Terminated

Conditions: Intractable Abdominal Pain Secondary to Inoperable Malignancy

Interventions: Procedure: Percutaneous celiac plexus neurolysis
Procedure: EUS-guided celiac ganglion neurolysis
Device: Olympus UM 2000
Device: B-D Quincke Type Point
Drug: Levobupivacaine

First Posted Date: 2015-02-05

Last Posted Date: 2019-01-30

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 3

Registration Number: NCT02356640

Locations: 🇨🇳
Chinese University of Hong Kong, Hong Kong, Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy